January 3, 2026 · Form 4 insider transaction
Snyder Mark Howard bought 7,611 shares of Halozyme Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.